Through our work with policymakers, Kidney Care Partners (KCP) advocates for policies that improve the coordination of care and the understanding of chronic kidney disease (CKD), lower the barriers that block patients from accessing and choosing treatments, expand and enhance research efforts, and that reform the economics underlying the kidney care landscape so that financial incentives are aligned with patient goals.
In all, KCP’s legislative goals are to promote legislation that will provide End Stage Renal Disease (ESRD) patients with better access to high-quality healthcare – both by improving patients’ ability to choose their insurance and by expanding research initiatives to identify innovative treatments – and securing the economic stability of the dialysis care infrastructure to ensure the future of kidney care.
With regard to Medicare’s ESRD program, KCP advocates for patient-centered improvements to the Medicare benefit, upon which more than 80 percent of individuals with kidney failure rely upon to cover the cost of their care.
See How Kidney Disease is Affecting Your State
The Chronic Kidney Disease Improvement in Research & Treatment Act
The bipartisan Chronic Kidney Disease Improvement in Research and Treatment Act (S.1971/H.R. 4065) was re-introduced in June 2021 by Senators Benjamin Cardin (D-MD) and Roy Blunt (R-MO) and Congresswoman Terri Sewell (D-AL) and Congressman Vern Buchanan (R-FL). If passed, the legislation would raise awareness of chronic kidney disease and end-stage renal disease while also improving understanding and promoting access to treatment.